The market wants to see Didipio achieve production targets, and if gold price can breakout like it looks like it may do, we will see OGC at $4 in 2022 imo
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling